Ares Genetics GmbH
About Ares Genetics GmbHAres Genetics GmbH in Vienna, Austria, was founded in 2017 and is a wholly-owned subsidiary of Curetis GmbH. Ares Genetics uses the proprietary GEAR database to research the genetic fundamentals of antibiotic resistance and to develop and commercialize novel solutions to improve the fast identification of antibiotic resistance in patients with microbial infections. In addition, Ares Genetics´ objective is to provide better tools for the accelerated research of novel antibiotics.
5 articles with Ares Genetics GmbH
Ares Genetics wins Austrian Digitization Award for Digital Products and Solutions ares-genetics.cloud for AI-powered Antibiotic Resistance Prediction awarded by Federal Ministry for Digital and Economic Affairs VIENNA, Austria, and GAITHERSBURG, Md., Oct. 05, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), announced today that its subsidiary Ares Genetics GmbH (Vienna, Austria; “Ares Genetics”) has won the Austrian Digitization Award. Ares Genetics has been selected by an
OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test
OpGen, Inc., announced that its subsidiary Ares Genetics GmbH has been nominated for the 40th Austrian Innovation Award.
OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers
Accurate identification of antibiotic resistance markers based on the ARESdb QIAGEN CLC Module leveraging Ares Genetics’ proprietary antibiotic resistance database Pathogens correctly identified with 100% sensitivity and specificity, antibiotic resistance markers with >95% sensitivity and >99% specificity, respectively Study paves the way for routine clinical diagnostic application of next-generation sequencing (NGS) in timely as well as accurate infectious disease testing and drug
Developing Sample to Insight solutions to accelerate research on growing public health threat
Ares Genetics GmbH Release: Company News: "GEAR – Predicting Antibiotic Resistances With Genetic Data" Succeeds In Competition “Landmarks In The Land Of Ideas”